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ith phosphodiesterase/phospho-triesterase, and by gel
ltration of molecular mass.
Results: The enzyme:
was widely distriibuted in animal. plant tissues, and in
microorganisms.
was associated with poliovirus, inﬂuenza virus, brome
mosaic virus, avian virus, southern
bean mosaic virus and mouse retrovirus
6-azauridine inhibits enzyme activity and the infectivity
of inﬂuenza virus on HeLa cells.
Conclusion: - An evolutionary signiﬁcant enzyme.
We speculate the enzyme is associated with the following
viral families: Flaviridae, Herpesviridae, Coronaviridae,
Picornaviridae, Papillomaviridae and Nipahviridae to
name a few.
6-azauridine inhibits on soluble form and virus bound
enzymes (Fig.3).
This investigation has been carried out on/off over two
decades in Department of Genetics, UW-Madison, US.
This presentation is dedicated to remember the late pro-
fessor Oliver E. Nelson, member of National Academy of
Science.
We are anxiously looking forward to collaborate with any
laboratory, institution, organization and industry in world-
wide to demonstrate quickly and precisely the existence
of this enzyme on surface of virions,i.e; mump, smallpox,
yellow fever, rubies, rubella, particularly HIV and H1N1
viruses and many others. Since we believe undoubedtly
that the results will contribute to understanding the pre-
vention, treatment and infectivity of viruses
6-Azauridine inhibits soluble enzyme activity
oi:10.1016/j.ijid.2010.02.639
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nfectious mononucleosis in Albanian children
. Petrela1,∗, E. Kallfa1, G. Lito1, H. Hoxha2, G. Mullalli 2,
. Como1
University Hospital Centre ‘‘Mother Theresa’’, Tirana, AL,
lbania
2University hospital center ‘‘Mother Theresa’’, Tirana,
lbania, Albania
Background: To study some of the epidemiological data,
linical manifestations, diagnosis and treatment of the chil-
ren hospitalized in the pediatrics infectious diseases ward.
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Methods: In the study are included 47 children from 1-
years hospitalized in Pediatrics Infectious Diseases Ward
uring 2003-2008. From the childrens cards we studied
mportant data as: distribution according to age group,
ender, residence, season and important clinical mani-
estation such as fever, fatigue, pharyngitis, generalized
ymphadenopathy and splenomegaly. Conﬁrmation of the
iagnosis is done by speciﬁc serological tests (antibody anti-
BV).
Results: According to age group 1-4 yr 30 cases (64%), 4-8
r 11 cases (23%), 8-14 yr 6 cases (13%); gender male 35 cases
74%), female 12 cases (26%); residence city 36 cases (76%),
illage 11 cases (24%); season spring 12 cases (25%), summer
cases (13%), autumn 11 cases (23%), winter 18 cases (39%).
linical manifestations: fever 47 cases (100%), Pharyngitis
hyperemic exudativ) 47 cases (100%), lymphadenopathy 37
ases (73%), cervicolatheral predominantly 25 cases (68%),
plenomegaly 15 cases (32%), hepatomegaly 7 cases (15%). In
5% of cases was found leucocitosis (10000-26000 cel/mm+),
typical lymphocytosis in peripheral blood (>10%), in 37
ases (79%) and elevated SGPT. Speciﬁc serological tests
or anti body anti-EBV (anti-VCA-IgG and anti-VCA-IgM) were
ositive in all cases.
12 cases (25%) resulted with pulmonary infections, 5
ases (10%) with urinary tract infections and 3 cases (6%)
ith biliary tract infection.
Conclusion: Infectious mononucleosis is a clinical syn-
rome caused by Epstein-Bar virus which is not rare and
ust be considered in pediatric population. This syn-
rome expressed clinically by the thriad; pharyngitis,
ymphadenopathy and splenomegaly must make us suspect
he diagnosis of infectious mononucleosis which is conﬁrmed
y speciﬁc serological tests. Therapy with corticosteroids for
hort periods (<2 weeks) is indicated only in complications
s airway obstruction, massive splenomegaly, myocardi-
is, hemolytic anemia, seizure, meningitis. Therapy with
cyclovir decreases viral replication and oropharyngeal
hedding but does not reduce the severity or durarion of
ymptoms.
oi:10.1016/j.ijid.2010.02.640
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ymptomatic, long-term Parvovirus B19 infection in oth-
rwise healthy adults
. Manfredi
University of Bologna, Bologna, Italy
Background: Parvoviridae are part of air-, parenteral- and
erinatal-transmitted ubiquitous viruses, whose associated
igns and symptoms strongly depend on patient’s age and
mmune defence.
Methods: All cases of symptomatic Parvovirus B19 infec-
ion in otherwise healthy adults which came to our attention
ince spring 2006 were prospectively investigated and fol-
owedup.
Results: In a 21-month period, 11 patients (7 females
nd 4 males), with a mean age of 36.9 (range 27-46) years
ith a symptomatic Parvovirus B19 infection were recorded
nd followed-up. Intrafamiliar exposure and occupational
health care) exposure were identiﬁed in two cases each.
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Clinical signs and symptoms included fever (100% of cases),
polyarthralgia (90%), followed by headache (80%), anemia
(70%), and rash. A mild-to-moderate myelosuppression of
all hematological lines characterized 8 cases of 11 (72.7%),
while increased serum transaminases were associated in
63.6% of patients. Three patients of ours deserved hospi-
talization (mean 10.8 days of admission), and ﬁve more
cases were followed on Day-Hospital basis (for a median
75-day period); in four patients a treatment with i.v. high-
dosage human immunoglobulins was performed. Elevated
levels of speciﬁc serum anti-Parvovirus B19 IgM antibod-
ies were detected in all cases. In a 33-year-old female a
severe anemia and a persisting headache, vomiting, and
neck stiffness, led to RBC transfusion and a diagnosis of
meningoencephalitis, with positive search of IgM antibodies
and Parvovirus B19 viremia (detected by RT-PCR) in the cere-
brospional ﬂuid which lasted up to three months, despite
treatment with i.v. serum immunoglobulins.
Conclusion: Parvovirus B19 infection may play a signif-
icant role also in adult, immunocompetent subjects, and
the disease sometimes is not mild and self-limiting, requir-
ing admission and/or frequent outpatient interventions in a
signiﬁcant number of cases. The causes supporting a per-
sistant infection in immunocompetent subjects have not
been investigated to date, as well as the pathogenesis of
myelosuppression and severe polyartrhalgia. Symptomatic
Parvovirus B19 infection is still an underestimated clinical
condition, and therapeutic perspectives are extremely lim-
ited until now.
doi:10.1016/j.ijid.2010.02.641
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etection of Sudan ebolavirus (strain Gulu) epitopes that
re targets of the humoral immune response in survivors
. Sobarzo1,∗, A. Groseth2, O. Dolnik2, S. Becker2, J.J.
utwama3, V. Yavelsky1, R.S. Marks4, L. Lobel1
Ben-Gurion University of the Negev, Beer Sheva, Israel
Institute of Virology, Philipps-University Marburg, Mar-
urg, Germany
Uganda Virus Research Institute, Entebbe, Uganda
Ben-Gurion University of the Negev, Beer-sheva, Israel
Background: Epidemics and pandemics have had a great
mpact on the course of human history. As such emergence
nd re-emergence of diseases of high risk to the individ-
al, and/or the community, are of speciﬁc interest and
oncern to public health systems, whether they be in devel-
ped or developing countries. Ebola viruses represent prime
xamples of such emerging pathogens. Ebola outbreaks are
npredictable, with high severity and fatality rates. This
igh case fatality rate of Ebola virus infection and the lack
f approved vaccines and therapeutics resulted in classiﬁ-
ation of Ebola viruses as biosafety level 4 pathogens and
otential bioweapons by the WHO and the CDC. The main
oal of this work is to identify epitopes within the viral pro-
eins of Sudan ebolavirus (strain Gulu) that are targets of the
umoral immune response in survivors. Epitope speciﬁc anti-
odies are important indicators of survival from this deadly
isease and can serve as templates for the development of
ynthetic or vectored vaccines
Methods: Using standard cloning techniques the Sudan
bolavirus (strain Gulu) genes for all seven structural pro-
eins were cloned and sequenced. For viral protein 24
VP24), 30 (VP30), 40 (VP40) and NP further expression con-
tructs were generated containing a Flag tag epitope for
etection. These proteins were expressed in 293T cell using
tandard techniques and transfection efﬁciency was con-
rolled by using a VP40-GFP fusion protein construct.
Following expression, viral proteins were isolated and
ested by western blot analysis.he expression of the recombinant viral protein of
bolavirus (strain Gulu) by western blot (WB) analysis
